Equinox® Syringes: Advancing Biotech and Biologics Applications
Equinox® Syringes provide an advanced solution for the precise and efficient delivery of biologics and other high-value biotech therapies, particularly for rare disease treatments where precision and stability are critical. Many rare disease therapies require low-volume injectable solutions, making the choice of a high-performance syringe essential to ensure accurate dosing and minimal waste. Additionally, Equinox® Syringes are completely silicone-free, preventing potential interactions that could compromise sensitive biologic formulations.
- Optimized Drug Delivery for Biologics
Biologics and peptide-based therapies are highly sensitive and often expensive. Equinox® Syringes are engineered to evacuate up to 98% of the drug, significantly reducing waste and ensuring cost-effective administration. This is particularly critical for biotech applications, where every microgram of therapeutic agent matters, especially in rare disease treatments where drug supply is often limited. - Superior Material Performance
Unlike traditional glass syringes, which are susceptible to delamination and breakage, Equinox® Syringes are made from advanced cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) materials. These materials provide superior chemical resistance, enhanced accuracy, and minimized drug absorption—factors essential for maintaining the integrity of biologics. Additionally, their 50% lighter weight reduces shipping costs and enhances handling safety. The absence of silicone further ensures that sensitive biologic formulations remain stable and uncontaminated. - Innovative Design for Biotech Applications
The Equinox® product line includes Comfort Grip and ISO syringes, along with low-profile caps that combine soft and rigid plastics for enhanced sealing. These features are particularly beneficial for biotech therapies requiring precise and contamination-free delivery. The silicone-free design ensures compatibility with a wide range of biologic formulations, preventing issues related to protein aggregation or particulate contamination. - Customization for Biologic Drug Formulations
Plas-Tech Engineering, the manufacturer of Equinox® Syringes, provides extensive expertise in designing syringe and cartridge bodies, plungers, and tips. They offer tailored material and coating solutions to meet the unique needs of biologic formulations, ensuring compatibility and optimal drug stability. - Versatile Sterilization and Packaging Options
Equinox® Syringes support multiple sterilization methods, including gamma, steam autoclave, EtO/EO, E-Beam, and X-ray. Custom packaging and labeling options further streamline pharmaceutical readiness, ensuring compliance with biotech industry requirements. - Ideal for Rare Disease Injectable Therapies
Many rare disease therapies require precise, low-volume injectable solutions. Equinox® Syringes are available in small quantities for early-stage material testing, extractable and leachable (E&L) studies, and clinical trials. Their high-precision design and low residual volume make them particularly well-suited for rare and orphan drug applications, where minimizing waste and ensuring stability are critical. Plas-Tech Engineering supports the entire product lifecycle, from small-batch production to full-scale commercial manufacturing, making it a trusted partner for rare disease and biologics companies.
With their advanced design, superior material properties, and robust manufacturing support, Equinox® Syringes offer unparalleled benefits for the delivery of biologic and biotech therapies. Their ability to ensure drug stability, minimize waste, and maintain regulatory compliance makes them an essential solution for pharmaceutical applications in this rapidly evolving field.